Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: PSF, SRI

Kubly Family Invests $5 Million to Establish a Suicide Prevention Research Program at the Medical College of Wisconsin


Dr. and Mrs. Michael C. Kubly Community-Based Suicide Prevention Research Program to Focus on Access and Interventions

MILWAUKEE, Sept. 23, 2022 /PRNewswire/ -- Mrs. Billie Kubly is investing $5 million to accelerate efforts to prevent suicide and increase access to behavioral health programs for patients and families at the Medical College of Wisconsin (MCW). The contribution establishes the Dr. and Mrs. Michael C. Kubly Community-Based Suicide Prevention Research Program and will be used to address the ongoing suicide crisis in the region and around the state.

Mrs. Kubly and her late husband Dr. Michael Kubly have a long history of advocacy and philanthropic investments to reduce the stigma around seeking mental health treatment and have supported the development of research-based interventions and therapies. Previous gifts to MCW included contributions benefitting families with young children in need of mental health services and establishing the Charles E. Kubly Chair in Psychiatry and Behavioral Medicine.

"I know that Mike would be pleased that this investment will help save lives in our community," said Mrs. Kubly. "MCW is a trusted community partner when it comes to mental health issues and has the capacity to bring together stakeholders who will be committed to reducing suicides."

The $5 million gift will be divided equally between two endowed funds. One fund will support a named faculty position for a nationally regarded leader to coordinate suicide prevention efforts, including research and community programming. The other fund will provide a source of income to support the work of this faculty member and others who are staffing and developing the programs and conducting new research.

The burden of suicide in Milwaukee, and throughout the country remains high. Suicide is the tenth leading cause of death in the United States and ranks second among individuals aged 10 to 34. In Wisconsin, suicide rates increased 40 percent between 2000 and 2017, particularly among vulnerable populations such as veterans and individuals living in the state's urban counties.

"The pandemic has highlighted the prevalence of mental health issues in our community," said Jon Lehrmann, MD, holder of the Charles E. Kubly Chair in Psychiatry and Behavioral Medicine, who sees patients at the Zablocki VA Medical Center. "The truth is that these conditions were already growing before the spread of COVID-19 and require an urgent community response."

"Billie has been a visionary and an inspirational leader for us, and this gift will have a far-reaching impact on our community," Dr. Lehrmann added.

SOURCE Medical College of Wisconsin


These press releases may also interest you

at 07:10
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET. To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...

at 07:05
Can-Fite BioPharma Ltd. , a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, today announced it received a Notice of Allowance from the European Patent Office for its...

at 07:05
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...

at 07:05
bluebird bio, Inc. announced today that it has completed the first commercial cell collection for LYFGENIA (lovotibeglogene autotemcel), a one-time gene therapy for the treatment of sickle cell disease in patients with a history of vaso-occlusive...

at 07:05
Xeris Biopharma Holdings, Inc. , a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies, today announced that it has entered into an exclusive...

at 07:01
Ginkgo Bioworks , which is building the leading platform for cell programming and biosecurity, today announced its participation in the 27th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting, May 7-11, in Baltimore, MD. Ginkgo will...



News published on and distributed by: